V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20219423 | 20175244 | 1.9 | 0 | Palliative (P) | 2018-07-19 | 2018-07-21 | Panitumumab + Irinotecan + MdG | N | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100262703 |
| 20219435 | 20175245 | 1.68 | 63.9 | Curative (C) | 2021-05-15 | 2021-07-26 | IRINOTECAN + MDG + PANITUMUMAB | N | Y | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101718338 |
| 20219436 | 20175246 | 1.66 | 73 | null | 2017-12-04 | 2017-12-19 | GO2 TRIAL | 02 | null | TRIAL | 101496915 |
| 20219459 | 20175247 | 0 | 67 | Palliative (P) | 2016-09-15 | 2017-03-02 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101791596 |
| 20219463 | 20175248 | 1.59 | 58.9 | null | 2017-05-30 | 2017-05-30 | IRINOTECAN + MDG + PANITUMUMAB | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101815784 |
| 20219485 | 20175249 | 1.76 | 110 | null | null | 2020-03-17 | EOX | 02 | null | CETUXIMAB + IRINOTECAN + MDG | 101147109 |
| 20219493 | 20175250 | 1.75 | 80.8 | Palliative (P) | null | 2018-08-26 | EOX | 02 | N | TRIAL | 100051411 |
| 20219515 | 20175251 | 1.65 | 70.6 | Curative (C) | 2017-12-28 | 2018-01-03 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100964114 |
| 20219516 | 20175252 | 1.72 | 84.6 | Palliative (P) | 2018-01-21 | 2018-01-27 | EOX | N | N | CETUXIMAB + IRINOTECAN + MDG | 100562788 |
| 20219535 | 20175253 | 1.65 | 83.8 | Palliative (P) | 2016-02-09 | 2016-06-20 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 100715724 |
| 20219572 | 20175254 | 1.74 | 68.2 | Palliative (P) | 2017-02-05 | 2017-02-27 | Trial Unspecified | 1 | N | TRIAL | 101645648 |
| 20219584 | 20175255 | 1.6 | 58.1 | null | 2016-08-21 | 2016-08-21 | CAPECITABINE + RT | null | null | CAPECITABINE + RT | 100714248 |
| 20219600 | 20175256 | 1.6 | 85.3 | Palliative (P) | 2017-02-15 | 2017-02-15 | Cetuximab + Oxaliplatin + MdG Load | 2 | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100865750 |
| 20219636 | 20175257 | 1.59 | 114.9 | 03 | 2019-11-15 | 2019-12-05 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100380310 |
| 20219645 | 20175258 | null | null | Palliative (P) | 2018-11-18 | 2018-12-01 | Sorafenib | 02 | N | SORAFENIB | 100984056 |
| 20219709 | 20175259 | 1.83 | 78.5 | Palliative (P) | 2018-12-07 | 2019-10-30 | EOX | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101866397 |
| 20219732 | 20175260 | null | 90.2 | Palliative (P) | 2019-03-16 | 2019-04-19 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | OXALIPLATIN + RALTITREXED | 101424888 |
| 20219746 | 20175261 | 1.75 | 82 | Palliative (P) | 2018-10-19 | 2018-12-01 | Cetuximab + Oxaliplatin + MdG Maint | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101434319 |
| 20219807 | 20175262 | 1.56 | null | null | 2015-07-29 | 2017-01-21 | EOX | 02 | null | EOX | 100044606 |
| 20219865 | 20175263 | 1.56 | 68.1 | Adjuvant (A) | 2019-11-08 | 2019-11-08 | EOX | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100037819 |
| 20219889 | 20175264 | 1.64 | 86.4 | 03 | 2017-09-15 | 2018-01-27 | Cetuximab + Oxaliplatin + MdG Load | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100176802 |
| 20219912 | 20175266 | 1.84 | 85.25 | null | 2017-05-14 | 2017-05-25 | EOX | 02 | null | CAPECITABINE + RT | 100171984 |
| 20219948 | 20175267 | 1.75 | 91 | Palliative (P) | 2020-05-04 | 2020-05-04 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101108994 |
| 20219975 | 20175268 | 1.63 | 103.9 | null | 2019-03-20 | 2019-04-14 | Oxaliplatin + Raltitrexed | 02 | null | OXALIPLATIN + RALTITREXED | 100179707 |
| 20219978 | 20175269 | 1.61 | 87 | Palliative (P) | 2016-12-14 | 2017-04-07 | EOX | 02 | N | CAPECITABINE + RT | 100119913 |
| 20219994 | 20175270 | 1.86 | 69.2 | Neo-adjuvant (N) | 2018-08-02 | 2018-10-19 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 101056989 |
| 20220061 | 20175271 | 1.51 | 76.9 | Palliative (P) | 2019-02-10 | 2019-02-15 | Sorafenib | 02 | N | SORAFENIB | 101638405 |
| 20220065 | 20175272 | 1.85 | 66.3 | Palliative (P) | 2018-10-23 | 2019-02-11 | EOX | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100503704 |
| 20220070 | 20175273 | 1.9 | 88 | null | 2021-07-15 | 2021-07-29 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101607846 |
| 20220091 | 20175274 | 1.87 | 71.5 | Palliative (P) | 2021-09-08 | 2021-11-11 | EOX | 02 | N | EOX | 100566479 |
| 20220163 | 20175275 | 1.53 | 104 | Palliative (P) | 2019-09-28 | 2019-10-05 | IRINOTECAN + MDG + PANITUMUMAB | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101768239 |
| 20220173 | 20175276 | 0 | 60 | null | 2017-02-08 | 2017-02-22 | EOX | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100927755 |
| 20220179 | 20175277 | 1.72 | 66.4 | Palliative (P) | 2017-07-01 | 2017-11-14 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101150997 |
| 20220240 | 20175278 | 1.67 | 102.6 | Adjuvant (A) | 2021-11-15 | 2021-11-19 | Cetuximab + Oxaliplatin + MdG Load | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100119118 |
| 20220243 | 20175279 | 1.71 | 61.3 | Palliative (P) | 2016-06-28 | 2016-07-15 | EOX | 02 | N | TRIAL | 100340220 |
| 20220299 | 20175280 | 1.63 | 77.3 | Palliative (P) | 2018-12-14 | 2019-05-12 | Capecitabine 35days + RT | 02 | N | CAPECITABINE + RT | 100788704 |
| 20220334 | 20175282 | 1.66 | 75 | Palliative (P) | 2017-05-13 | 2017-12-01 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101443742 |
| 20220335 | 20175283 | 1.7 | 69.4 | Neo-adjuvant (N) | 2017-04-08 | 2017-04-09 | Sorafenib | 2 | null | SORAFENIB | 101585415 |
| 20220344 | 20175284 | 1.72 | 75 | Palliative (P) | 2016-02-18 | 2016-10-11 | EOX | N | N | CETUXIMAB + IRINOTECAN + MDG | 101285395 |
| 20220352 | 20175285 | 1.63 | 77.6 | Palliative (P) | 2017-11-21 | 2018-06-24 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | SORAFENIB | 101225375 |
| 20220389 | 20175286 | 1.83 | 78.8 | Palliative (P) | 2017-07-07 | 2017-09-08 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101684051 |
| 20220397 | 20175287 | 1.59 | 60 | null | 2016-02-22 | 2016-09-26 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 100387687 |
| 20220423 | 20175288 | 1.56 | 96.1 | null | 2017-02-07 | 2017-02-07 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101345823 |
| 20220484 | 20175289 | 1.65 | 93.3 | null | 2018-07-13 | 2020-01-01 | EOX | 02 | null | CAPECITABINE + RT | 100533095 |
| 20220493 | 20175290 | 1.83 | 55 | Curative (C) | 2019-10-05 | 2019-10-06 | Sorafenib | 02 | N | SORAFENIB | 101463349 |
| 20220495 | 20175291 | 1.7 | null | Palliative (P) | 2019-03-20 | 2019-04-01 | EOX | N | N | CAPECITABINE + RT | 101388176 |
| 20220499 | 20175292 | 1.66 | 61.95 | null | 2019-10-23 | 2020-07-05 | Cetuximab + Oxaliplatin + MdG Load | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100678516 |
| 20220591 | 20175293 | 1.78 | 83.1 | null | 2017-05-29 | 2017-06-05 | EOX | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101738612 |
| 20220604 | 20175294 | 1.71 | 73.4 | Palliative (P) | 2017-06-11 | 2017-06-15 | Sorafenib | 01 | Y | CETUXIMAB + IRINOTECAN + MDG | 100280549 |
| 20220624 | 20175295 | 1.81 | 67.4 | Palliative (P) | 2019-10-26 | 2020-01-12 | EOX | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 100526319 |